HIGHLIGHT
Rybelsus

Rybelsus Overdosage

semaglutide

Manufacturer:

Novo Nordisk

Distributor:

Zuellig Pharma

Marketer:

Novo Nordisk
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Overdosage
Effects of overdose with semaglutide in clinical studies may be associated with gastrointestinal disorders. In the event of overdose, appropriate supportive treatment should be initiated according to the patient's clinical signs and symptoms. A prolonged period of observation and treatment of the symptoms may be necessary, taking into account the long half-life of semaglutide of approximately 1 week (see Pharmacology: Pharmacokinetics under Actions). There is no specific antidote for overdose with semaglutide.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in